Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)-Reference-Cited by-同舟云学术

Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)

Published:2018-07-10 Issue:11 Volume:20 Page:2670-2674
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ferrières Jean¹²^ORCID,Lautsch Dominik³,Gitt Anselm K.⁴⁵,De Ferrari Gaetano⁶,Toplak Hermann⁷,Elisaf Moses⁸,Drexel Heinz⁹¹⁰¹¹,Horack Martin⁵,Baxter Carl¹²,Ambegaonkar Baishali³,Brudi Philippe³,Toth Peter P.¹³¹⁴

Affiliation:

1. Department of CardiologyToulouse Rangueil University Hospital Toulouse France

2. Department of Epidemiology and Public HealthUMR INSERM 1027, Toulouse University School of Medicine Toulouse France

3. Merck & Co. Inc. Kenilworth New Jersey

4. Herzzentrum Ludwigshafen Ludwigshafen Germany

5. Stiftung Institut für Herzinfarktforschung Ludwigshafen Germany

6. Department of CardiologyIRCCS Fondazione Policlinico San Matteo, and University of Pavia Pavia Italy

7. Lipid Clinic, Department of MedicineMedical University of Graz Graz Austria

8. School of MedicineUniversity of Ioannina Ioannina Greece

9. Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT) Feldkirch Austria

10. Department of Medicine and CardiologyPrivate University of the Principality of Liechtenstein Triesen Liechtenstein

11. Department of Medicine Division of CardiologyDrexel University College of Medicine Philadelphia Pennsylvania

12. MSD Ltd Hoddesdon UK

13. CGH Medical Center Sterling Illinois

14. Ciccarone Center for the Prevention of Heart DiseaseJohns Hopkins University School of Medicine Baltimore Maryland

Funder

Merck

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13415

Reference15 articles.

1. BMI and all cause mortality: systematic review and non‐linear dose‐response meta‐analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants;Aune D;BMJ,2016

2. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

3. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants

4. Mechanisms linking obesity with cardiovascular disease

5. Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriateness of Intensive Statin Treatment in People with Type Two Diabetes and Mild Hypercholesterolemia: A Randomized Clinical Trial;Archives of Iranian Medicine;2023-06-01

2. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies;European Journal of Preventive Cardiology;2023-04-11

3. Investigating the effects of statins on ischemic heart disease allowing for effects on body mass index: a Mendelian randomization study;Scientific Reports;2022-03-03

4. Novel insights into the consequences of obesity: a phenotype-wide Mendelian randomization study;European Journal of Human Genetics;2022-01-01

5. Determining the effect size of aerobic exercise training on the standard lipid profile in sedentary adults with three or more metabolic syndrome factors: a systematic review and meta-analysis of randomised controlled trials;British Journal of Sports Medicine;2021-06-30